Norifumi Sawamukai

Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study

Yoshiya Tanaka, Shintaro Hirata, Satoshi Kubo et al. · Annals of the Rheumatic Diseases · 2013 · 199 citations · Full text

Veterinary Medicine, Immunology, Internal Medicine +17

Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus

Jun Ishizaki, Kuniaki Saito, Masao Nawata et al. · Lara D. Veeken · 2014 · 79 citations · Full text

Medicine, Nephrology, Pathology +17

Tacrolimus, a Calcineurin Inhibitor, Overcomes Treatment Unresponsiveness Mediated by P-glycoprotein on Lymphocytes in Refractory Rheumatoid Arthritis

Katsunori Suzuki, Kazuyoshi Saito, Shizuyo Tsujimura et al. · The Journal of Rheumatology · 2010 · 64 citations · Full text

Medicine, Immunology, Pharmacology +17

Incidence and risk factors for reactivation from resolved hepatitis B virus in rheumatoid arthritis patients treated with biological disease‐modifying antirheumatic drugs

Toshiyuki Watanabe, Jun Fukae, Shinji Fukaya et al. · International Journal of Rheumatic Diseases · 2018 · 60 citations

Medicine, Internal Medicine, Pharmacotherapy +17

C5a promotes migration, proliferation, and vessel formation in endothelial cells

Ryuji Kurihara, Kunihiro Yamaoka, Norifumi Sawamukai et al. · Inflammation Research · 2010 · 54 citations · Full text

Life Sciences, Cell Biology, Immunology +16